| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2020 | WAT Waters Corp /de/ | Oconnell Christopher J | CEO And President | Sell | 30,000 | $213.30 | $6,399,000.00 | -52.1% | |
| Jul 31, 2020 | EXAS Exact Sciences Corp | Doyle James Edward75 | Director | Sell | 2,539 | $94.00 | $238,666.00 | -7.3% | |
| Jul 31, 2020 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 37,500 | $93.83 | $3,518,771.01 | -10.4% | |
| Jul 31, 2020 | EXAS Exact Sciences Corp | Carey Thomas D. | Director | Sell | 30,620 | $94.00 | $2,878,280.00 | -58.3% | |
| Jul 31, 2020 | RVTY Revvity, Inc. | Goldberg Joel S58 | Please See Remarks | Sell | 23,387 | $117.84 | $2,755,824.94 | -13.4% | |
| Jul 31, 2020 | EXAS Exact Sciences Corp | Levangie Daniel J | Director | Sell | 9,865 | $94.00 | $927,310.00 | -39.6% | |
| Jul 31, 2020 | VCYT Veracyte, Inc. | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sell | 20,000 | $35.33 | $706,694.00 | -19.9% | |
| Jul 31, 2020 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 40,000 | $407.17 | $16,286,600.00 | -7.7% | |
| Jul 30, 2020 | NEO Neogenomics Inc | Shovlin Robert J. | President, Clinical Services | Sell | 81,356 | $38.17 | $3,105,358.52 | -35.4% | |
| Jul 30, 2020 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 11,365 | $32.24 | $366,398.51 | -4.0% | |
| Jul 30, 2020 | MEDP Medpace Holdings, Inc. | Burwig Susan E64 | Exec. VP, Operations | Sell | 6,000 | $121.14 | $726,840.00 | -11.5% | |
| Jul 30, 2020 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 72,716 | $95.76 | $6,963,575.02 | -12.6% | |
| Jul 30, 2020 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 90,061 | $122.46 | $11,029,207.39 | -0.6% | |
| Jul 30, 2020 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 90,061 | $122.46 | $11,029,207.39 | -0.6% | |
| Jul 29, 2020 | TMO Thermo Fisher Scientific Inc. | Williamson Stephen68 | Sr. VP And CFO | Sell | 19,800 | $410.83 | $8,134,471.20 | -14.8% | |
| Jul 29, 2020 | RVTY Revvity, Inc. | Okun Andrew76 | Please See Remarks | Sell | 6,699 | $120.00 | $803,880.00 | -39.4% | |
| Jul 29, 2020 | DHR Danaher Corp /de/ | McGrew Matthew66 | EVP &Chief Financial Officer | Sell | 7,457 | $203.42 | $1,516,925.31 | -37.6% | |
| Jul 29, 2020 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 40,000 | $411.34 | $16,453,415.47 | -2.6% | |
| Jul 29, 2020 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 8,746 | $95.58 | $835,942.68 | -11.2% | |
| Jul 29, 2020 | WST West Pharmaceutical Services Inc | Montecalvo David A | SVP, Glob Ops And Supply Chain | Sell | 17,781 | $265.91 | $4,728,060.54 | -25.0% | |
| Jul 28, 2020 | IQV Iqvia Holdings Inc. | Tpg Group Holdings (sbs) Advisors, Inc.86 | Former Director | Sell | 2,919,051 | $159.12 | $464,479,395.12 | -100% | |
| Jul 28, 2020 | EXAS Exact Sciences Corp | Zanotti Katherine S50 | Director | Sell | 1,164 | $96.13 | $111,895.32 | -2.7% | |
| Jul 28, 2020 | DHR Danaher Corp /de/ | Lohr Walter G51 | Director | Sell | 57,000 | $198.56 | $11,317,692.00 | -12.7% | |
| Jul 28, 2020 | DHR Danaher Corp /de/ | King William | SVP, Strategic Development | Sell | 26,982 | $199.09 | $5,371,878.42 | -38.5% | |
| Jul 28, 2020 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 243,518 | $125.23 | $30,495,275.94 | -1.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.